参考文献/References:
[1] DE VILA FERNANDES E,SANDIM GB,MITRAUD SA,et al.Sono graphic description and classification of tendinous involvement in relation to tophaceous gout[J].Insights Imaging,2010,12(6):143-148.
[2] 路杰,崔凌凌,李长贵.原发性痛风流行病学研究进展[J].中华内科杂志,2015,54(3):244-247.
[3] DALBETH N,JONES G,TERKELTAUB R,et al.Efficacy and safety during extended treatment of lesinurad in combination with febuxostat in patients with tophaceous gout:crystal extension study[J].Arthritis Res Ther,2019, 21(1):8.
[4] NEOGI T,JANSEN T L,DALBETH N,et al. 2015 Gout classification criteria:an american college of rheumatology/european league against rheumatism collaborative initiative[J]. Arthritis & Rheumatology,2015,67(10):2557-2568.
[5] SARI I,AKAR S,PAKOZ B,et al. Hyperuricemia and its related factors in an urban population,Izmir,Turkey[J].Rheumatology International,2009,29(8):869-874.
[6] ZHAI F,HE Y,MA G,et al. Study on the current status and trend of food consumption among Chinese population[J].Chinese Journal of Epidemiology,2005,26(7):485-488.
[7] LIU R,HAN C,WU D,et al. Prevalence of hyperuricemia and gout in mainland china from 2000 to 2014:a systematic review and meta-analysis[J].Biomed Res Int,2015,2015:62820.
[8] 朱震亨.丹溪心法[M].赵建新点校.北京:人民军医出版社,2007:76.
[9] 姚祖培,陈建新.朱良春治疗痛风的经验[J].中医杂志,1989(3):16-17.
[10] 路洁,魏华.路志正教授治疗痛风的学术思想[J].浙江中医学院学报,2005,29(6):30-31.
[11] SO A K,MARTINON F. Inflammation in gout:mechanisms and therapeutic targets[J].Nat Rev Rheumatol,2017,13(11):639-647.
[12] CHEN J,WU M,YANG J,et al. The immunological basis in the pathogenesis of gout[J].Iran J Immunol,2017,14(2):90-98.
[13] 付璟,石继和.黄芩素体外抑菌与体内抗炎作用研究[J]. 中国药房,2014,25(23):2136-2138.
[14] 张倩,李惠香,刘攀,等. 黄芩素的体外抗炎及抗氧化活性研究[J]. 烟台大学学报:自然科学与工程版,2018,31(3):232-238.
[15] 李宇馨,李瑞海. 苍术挥发油抗炎活性研究[J]. 辽宁中医药大学学报,2013,15(2):71.
[16] 邓时贵,胡学军,李伟英,等. 茅苍术挥发油主要化学成分的稳定性及其抗炎作用的初步比较[J]. 辽宁中药杂志, 2008,35(11):1733.
[17] 于艳,贾天柱,才谦. 茅苍术及其麸炒品对胃溃疡大鼠抗炎作用的比较研究[J]. 中国中药杂志,2016,41(4):705-710.
[18] 吴月国,张萍,赵铮蓉,等.薏苡仁提取物的镇痛活性部位筛选[J]. 中国现代应用药学,2012,29(6):503-506.
[19] 吴建方. 薏苡仁提取物的抗炎、镇痛、镇静作用研究[J]. 转化医学电子杂志,2015,2(12):56-57.